Villeneuve-d'Ascq, France · Founded 2020 · Privately Held (backing)
Operator of a biotechnology platform intended to treat resistant tumors using proprietary photosensitizing molecules paired with advanced laser light technologies. Hemerion Therapeutics is based in Villeneuve-d'Ascq, France and was founded in 2020. Its last reported valuation was $26.2 million in May 2025. It has raised $14.2 million.
Last reported valuation
$26.2M
Oct 2026
Priced at
—
Total raised
$14.2M
Last round
—
Team — not yet on record
No current team members for Hemerion Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hemerion Therapeutics with a free account
·Watch Hemerion Therapeutics: the Monday email on marks, rounds and moves
